The epidemiology of abdominal adiposity:validation and application of ultrasonography to estimate visceral and subcutaneous abdominal fat and to identify their early life determinants by De Lucia Rolfe, Emanuella
  
 University of Groningen
The epidemiology of abdominal adiposity
De Lucia Rolfe, Emanuella
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2012
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
De Lucia Rolfe, E. (2012). The epidemiology of abdominal adiposity: validation and application of
ultrasonography to estimate visceral and subcutaneous abdominal fat and to identify their early life
determinants. Groningen: s.n.
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
   

























1. Obesity – definition and classification 
 
Obesity has become a major global public health issue and its prevalence has increased 
drastically over the last decades among all ages (1,2). The increased availability and 
consumption of high energy dense foods, containing high levels of saturated fats and refined 
sugars combined with physical inactivity, have probably led to this rise (2). It is estimated that by 
2015 the populations of overweight and obese adults will increase to 2.3 billion and 700 million 
respectively and that the number of overweight children under the age of five will be over 42 
million (2).  
Obesity is associated with increased risk of type 2 diabetes, hypertension, cardiovascular disease 
and breast cancer (3-5) and may significantly impair individuals’ quality of life (6). Therefore, 
this condition and associated complications have a substantial impact on countries health care 
systems and the economic burden is only likely to increase as the prevalence of overweight and 
obesity rises. Furthermore, the obesity epidemic is not restricted to developed countries, but it is 
also affecting developing countries, where this condition often co-exists with undernutrition (2) 
creating a ‘double burden’ of disease that threatens to overwhelm the health services of many of 
these countries (7) .  
 
Table 1: WHO classification of weight status in adults  
BMI Classification 
< 18.5 underweight 
18.5–24.9 normal weight 
25.0–29.9 overweight 
30.0–34.9 class I obesity 
35.0–39.9 class II obesity 
≥ 40.0 class III obesity 
Source: Adapted from WHO, 2000 
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Obesity is clinically defined as a condition of fat accumulation associated with increased 
morbidity and mortality (2). Body mass index (BMI) is commonly used to classify overweight 
and obesity in adults (Table 1). It is a simple index of weight-for-height and it is defined as the 
weight in kilograms divided by the square of the height in metres (kg/m2). In children, the 
relationship between BMI and adiposity is age and sex dependent due to changes in body 
composition during growth (8). Therefore, age and sex-specific BMI cut off values are used and 
overweight and obesity are commonly classified using the 85th and 95th percentiles cut offs 
respectively (8, 9). In children under the age of 2 years, overweight is defined by weight-for-
length ≥ 95th percentiles (9). 
 
 
2. The importance of fat distribution  
 
Although excess body weight is predictive for total body fat and remains an important indicator 
of weight-related illness, anatomical distribution of body fat is at least equally if not more 
significant. Numerous epidemiological studies have demonstrated that increased abdominal 
adiposity may contribute to the development of the cluster of metabolic risk factors (glucose 
intolerance, insulin resistance, low concentrations of HDL-cholesterol, elevated triglycerides, 
hypertension and obesity) (10-13). In the 1940s, Jean Vague already demonstrated that an 
android or male fat pattern, which consists of greater fat in the upper body region, is related to 
unfavourable metabolic profile. In contrast, a gynoid or female fat pattern, with relatively greater 
fat in the hip and thigh areas, is not associated with metabolic complications of obesity (14). 
Therefore, the accumulation of fat in different body compartments may carry differential 
metabolic risks (15). In particular, the visceral adipose tissue (VAT) compartment, which is 
located inside the peritoneal cavity between the abdominal organs, may be a unique pathogenic 
fat depot (16-18). VAT has been found to be more closely related to obesity-associated 
pathologies and complications than either total adipose tissue (TAT) or subcutaneous adipose 
tissue (SCAT) (19, 20). VAT is considered to be more sensitive to lipolytic stimuli than the other 
adipose tissues (21). Visceral obesity leads to an increase in the production of free fatty acids, 
which then accumulate in ectopic sites such as the muscle, in the liver and in the pancreas 




development of type 2 diabetes). Free fatty acids also provide substrates for hepatic triglycerides 
production and thus may contribute to dyslipidemia (22). VAT also releases free fatty acids 
directly into the portal vein and therefore into the liver causing reduced hepatic insulin clearance 
and increased gluconogenesis in the liver (21, 22). The ratio between different abdominal fat 
regions, VAT to SCAT, has also been found to be an important indicator of an unfavourable 
metabolic profile (23). Taksali and colleagues have suggested that individuals with a high 
proportion of visceral fat relative to abdominal subcutaneous fat have more adverse metabolic 
profiles compared to those with the opposite phenotype (23). 
Although VAT has been found to be the most strongly related fat depot to metabolic 
disturbances, the role of SCAT in disease risk is still controversial. A recent animal study has 
demonstrated that subcutaneous fat has a beneficial effect on glucose metabolism when 
transplanted subcutaneous flank fat from donor mice into subcutaneous or visceral regions of 
recipient mice (24). However, earlier studies in humans had shown that removal of subcutaneous 
fat by liposuction does not result in changes of any aspect of metabolic syndrome, but no human 
studies have yet examined the possible beneficial metabolic effects of subcutaneous fat (25, 
26). Other studies in humans, have suggested that in some non-Caucasian populations, 
abdominal subcutaneous fat might actually have a deleterious role and it might be a significant 
predictor of adverse metabolic consequences (27-29). Therefore, accurate quantification of both 
VAT and SCAT mass in large studies and in different settings might help to elucidate the 
metabolic differences between these two abdominal fat depots. 
 
 
3. Critical time periods for fat accumulation 
 
Several epidemiological studies have shown that early life factors such as impaired or excess 
weight change, as well as periods of rapid ‘catch up’ growth, might be important in promoting 
obesity and associated co-morbidities (30-34). Intrauterine environment and rapid weight gain 
after birth have been suggested to contribute significantly in programming body composition and 
growth (35, 36). Foetal growth restriction is known to impact on adipose tissue development in 
utero (37) and low birth weight has been associated with a tendency to store fat centrally (38-40). 
Furthermore, children who were born small and showed catch up growth in the first 2 years of  
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life had greater percentage body fat and central fat distribution than other children at age five 
years (41). However, these studies mainly focused on overall adiposity and central adiposity, 
whereas very few have distinguished between the contributions of visceral and subcutaneous 
abdominal fat compartments. In the first two years of life, there is substantial increase in total 
body fat which rises from 12% at 0.5 months to 25.4% at 24 months (42). However, the time 
course for the development of VAT is poorly defined in the literature and there are no published 
data that have examined longitudinal changes in VAT and SCAT in the first years of life. Uthaya 
and colleagues have found that newborns with low birth weight have increased VAT at birth 
(43). Therefore it would be important to more precisely characterise the timing of the 
development of this fat compartment in early life; and investigate whether early life factors that 
have been related to long term obesity and related metabolic complications may be associated 
with the quantity of visceral fat. Accurate and widely applicable measures of these abdominal fat 
depots are needed to help answering these key questions. 
 
 
4. Measurements of abdominal fat distribution 
 
Imaging techniques such as Computed Tomography (CT) and Magnetic Resonance Imaging 
(MRI) represent the gold standards for the quantification of visceral and abdominal subcutaneous 
adipose tissues (44). However, the routine use of these methods is limited in large-scale-
population studies and repeated investigations due to ethical and practical constraints, mainly due 
to burden to participants, analytical cost, limited availability of those instruments for research 
purposes, poor co-operation when dealing with children and exposure to significant quantity of 
ionising radiation (CT only) (44-46). Furthermore, these methods are unlikely to be feasible 
between the ages 3-4 months to 5-6 years as sedation or general anaesthesia is usually required 
for clinical scans at these ages. 
Epidemiological studies generally implement simple anthropometry (e.g. BMI, waist-to-ratio, 
skinfolds and waist and hip circumference) to evaluate adiposity as they correlate with metabolic 
markers and imaging estimates (47). However, these measures are poor at discriminating visceral 
from subcutaneous fat regions (48, 49) and they are often characterized by low accuracy and 





these fat regions. For instance, at the same adiposity, Caucasian adults and children have been 
found to have higher visceral adipose tissue and lower subcutaneous fat than their Black 
counterparts (52-58). Furthermore, anthropometric indicators may not capture body composition 
changes that occur with aging (49). Muscle mass decreases, fat mass increases and becomes 
more centralised in the abdominal region (49).  
Ultrasonography has been suggested to be an alternative method to estimate fat distribution (44, 
59-61), it can accurately differentiate subcutaneous from visceral fat compartments and, it has 
been demonstrated to be a non invasive, reliable and reproducible method for the determination 
of these fat regions when compared to both CT and MRI techniques (44, 59-61). Therefore, this 
technique has the potential to be a valuable tool for the assessment of possible risk factors 
associated with obesity. However, those validation studies were carried out in women, obese 




OBJECTIVES OF THIS THESIS: 
 
In this thesis, I therefore assess the validity of ultrasonography to estimate the visceral and subcutaneous 
abdominal fat compartments in populations covering a wide range of ages. I then apply these measures 
to examine the role of early life factors that may influence the quantity of these fat depositions. 
 
Specifically, I formulated the following objectives: 
1. To investigate the validity and reproducibility of ultrasonography for the measurement of 
abdominal adiposity in different age groups (during infancy, childhood, adolescence, and in the 
elderly) and different ethnic populations (Caucasians and Black South Africans). 
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OUTLINE OF THE THESIS: 
 
The first part of this thesis (Chapters 2-4 and the first part of Chapter 6) focuses on the validity of 
ultrasonography to estimate abdominal fat compartments in different populations. In chapter 2, I 
assessed the validity of ultrasound measures of visceral and subcutaneous abdominal fat in older men 
and women, compared to MRI. I explored whether the addition of ultrasound measures to conventional 
anthropometry would increase the accuracy to predict these abdominal fat compartments. It was 
essential to validate the ultrasound protocol in an adult population as this method was applied in the 
study described in chapter 5. Chapter 3 tested the accuracy of the prediction equations for estimating 
VAT and SCAT developed in chapter 2 in South African adolescents using MRI measures as criterion; 
and derived new prediction models specific for this population. Chapter 4 describes the validation of 
ultrasonography and anthropometric measures to assess abdominal adiposity in prepubertal children. In 
chapter 6, I assessed the validity of ultrasound to estimate abdominal adiposity in newborn infants.  
In the second part of this thesis, I applied these ultrasound measures to explore the role of early life 
determinants of the abdominal fat depositions. In particular, in chapter 5, I investigated the associations 
between birth weight and adult visceral and subcutaneous-abdominal fat using ultrasonography in adults 
in the population-based Fenland Study. I hypothesized that birth weight might have differential 
associations with adult visceral and subcutaneous-abdominal fat. Chapter 6 examines the changes in 
abdominal fat during infancy and identifies associations between early growth parameters and different 
abdominal fat compartments in the first year of life in the Cambridge Baby Growth Study. I also 
explored whether early nutrition (e.g. breastfeeding and formula feeding) were related to these 
abdominal compartments.  
Finally, in chapter 7, the main findings are summarised, methodological issues are discussed and 
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